Register Login
Register to leave comments
  • News bot June 17, 2026, 8:02 p.m.

    📋 CARTESIAN THERAPEUTICS, INC. (RNAC) - Regulatory Update

    Filing Date: 2026-06-17

    Accepted: 2026-06-17 16:01:15

    Event Type: Regulatory Update

    Event Details:

    CARTESIAN THERAPEUTICS, INC. (RNAC) Announces Regulatory Update CARTESIAN THERAPEUTICS, INC. (RNAC) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development:

    🔬 Clinical Development Pipeline (CARTESIAN THERAPEUTICS, INC.):

    Product Type Development Stage Therapeutic Area Source
    Cyclophosphamide Other Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Fludarabine Other Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Descartes-08 Other Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Descartes 08 Other Phase PHASE2 Myeloma Multiple ClinicalTrials.gov
    Descartes 30 Other Phase PHASE1 Acute Respiratory Distress Syndrome ClinicalTrials.gov
    Descartes-25 Other Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Descartes 11 Other Phase PHASE2 Multiple Myeloma ClinicalTrials.gov
    Descartes-11 Other Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Descartes-15 Other Phase PHASE1 Refractory Multiple Myeloma ClinicalTrials.gov
    Placebo Drug Drug Phase PHASE3 Myasthaenia Gravis ClinicalTrials.gov
    Decartes-08 Other Phase PHASE3 Myasthaenia Gravis ClinicalTrials.gov
    Placebo Other Phase PHASE2 Antisynthetase Syndrome ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: CARTESIAN THERAPEUTICS, INC.
    • Ticker Symbol: RNAC

Search

News categories